Genome‐wide mutation analyses of neuroblastomas have not identified genetic abnormalities in MEGF104, 5, 6 and there was only infrequent (4/46; 7%) hypermethylation of MEGF10 in tumor tissue (Figure 3A and E). This evidence concerns the gene MEGF10 and neuroblastoma.